☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

HPV debate continues

The British Medical Journal (BMJ) has published an economic evaluation that aimed to assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus (HPV) infection.

The Department of Health recently announced that the national programme contract had been awarded to Cervarix® with details of the price remaining confidential. This evaluation estimates that Cervarix® should be costing between £13 and £21 per dose less that the quadrivalent alternative Gardasil®.

There is continued debate over the choice of vaccine (Times and Guardian) accusing the government of selecting an inferior vaccine in order to save money. This article in the BMJ is likely to further inflame the debate and may generate patient questions in primary care.

Action: Clinicians should be aware of the current situation and ongoing debate regarding HPV vaccination.

Share 'HPV debate continues' by emailShare 'HPV debate continues' on FacebookShare 'HPV debate continues' on TwitterShare 'HPV debate continues' on MastodonShare 'HPV debate continues' on LinkedInShare 'HPV debate continues' on reddit

atomic-wealth

2 Comments to “HPV debate continues”

  1. [...] decision to use Cervarix® has been criticised but this announcement does start to explain why the programme is using an apparently inferior [...]

    Pingback by Prescribing Advice for GPs » HPV programme extended — July 28, 2008 #
    Reply

  2. […] decision to use Cervarix® has been criticised but this announcement does start to explain why the programme is using an apparently inferior […]

    Pingback by HPV programme extended | Prescribing Advice for GPs — July 28, 2008 #
    Reply

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.